Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05253170 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy Patients

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Secondary endpoints: details revised at 1 of 4 entriesv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This randomized Phase III study aims to show major complication rate of hypofractionation radiation therapy is not inferior, compared to conventional fractionation radiation therapy in breast cancer patients undergoing mastectomy and reconstruction surgery.
Trial Details
NCT Number NCT05253170
Lead Sponsor Seoul National University Bundang Hospital
Collaborators: Seoul National University Hospital
Conditions
(from sponsor)		 Breast Cancer, Radiotherapy; Complications
Related terms Breast Neoplasms
Enrollment 622 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov